RSS Atom • ISSN 1472-4683 • Subscribe • About
Resistance
- Free online resource for treatment decisions without access to genotype resistance tests Conference reports - Resistance - IAS 6 Rome 2011 - 1 August 2011
- Minority M184V variants detected in women after receiving 3TC/FTC and LPV/r-containing regimens in pregnancy Conference reports - PMTCT and maternal health - Resistance - HIV 10 Glasgow 2010 - 1 December 2010
- Darunavir-associated mutations in PI-naive and PI-experienced children in the UK Conference reports - Paediatric care - Resistance - CROI 17 (Retrovirus) 2010 - 1 June 2010
- Rate of accumulation of TAMS slow in patients continuing on failing AZT or d4T containing regimens Resistance - 30 December 2009
- Transmitted multidrug-resistant HIV persists in PBMC DNA for years Conference reports - Resistance - Intl Drug Resistance Workshop 18 Florida 2009 - 22 August 2009
- Low-level Q148R in people without integrase inhibitor experience Conference reports - Resistance - Intl Drug Resistance Workshop 18 Florida 2009 - 22 August 2009
- Cut-offs suggested for predicting efavirenz failure with low-level K103N Conference reports - Resistance - Intl Drug Resistance Workshop 18 Florida 2009 - 22 August 2009
- Lower M184V rates with FTC/TDF than with 3TC/TDF Conference reports - Resistance - Intl Drug Resistance Workshop 18 Florida 2009 - 22 August 2009
- HBV resistance to lamivudine at undetectable and low levels of viremia Conference reports - Hepatitis coinfection - Resistance - Intl Drug Resistance Workshop 18 Florida 2009 - 22 August 2009
- Integrase inhibitor resistance and cross-resistance: weighing viral fitness and the option to benefit from second-generation compounds Conference reports - Resistance - Intl Drug Resistance Workshop 17 Sitges 2008 - 30 August 2008
- Understanding etravirine susceptibility: new weighted genotype score and phenotypic cut-offs Conference reports - Resistance - Intl Drug Resistance Workshop 17 Sitges 2008 - 30 August 2008
- Lack of virological impact of treatment intensification in suppressed patients supports latent viral reservoir as source of residual viraemia Conference reports - Resistance - Intl Drug Resistance Workshop 17 Sitges 2008 - 30 August 2008
- NNRTI resistance in infants prophylaxed with single-dose nevirapine varies by the timing of infection Conference reports - Resistance - Intl Drug Resistance Workshop 17 Sitges 2008 - 30 August 2008
- Detecting viral tropism: impact of a more sensitive Trofile (ES) assay Conference reports - Resistance - Intl Drug Resistance Workshop 17 Sitges 2008 - 30 August 2008
- Low frequency K103N mutations are associated with poor virological response to NNRTI based therapy Conference reports - Resistance - Intl Drug Resistance Workshop 17 Sitges 2008 - 30 August 2008
- Background drugs and low maraviroc levels explain resistance in Motivate studies Conference reports - Resistance - HIV Entry Workshop 3rd 2007 - 1 February 2008
- Dual-class mutations affection RTI and NNRTI may be common in experienced patients Resistance - 1 February 2008
- Integrase inhibitors and resistance Conference reports - Resistance - Intl Drug Resistance Workshop 16 Barbados 2007 - 7 July 2007
- Treatment failure and tropism changes in maraviroc trial related to previously undetected CXCR4, rather than a mutational shift from CCR5 Conference reports - Resistance - Intl Drug Resistance Workshop 16 Barbados 2007 - 3 July 2007
- Mechanisms of failure to CCR5 inhibitors is not explained by mutation in the V3 loop, cross-resistance between CCR5 inhibitors is likely Conference reports - Resistance - Intl Drug Resistance Workshop 16 Barbados 2007 - 3 July 2007
- Higher risk of resistance using lopinavir/r monotherapy Conference reports - Resistance - Intl Drug Resistance Workshop 16 Barbados 2007 - 3 July 2007
- Macaque study shows similar protection from rectal exposure using 2-hour pre- and 24-hour post exposure prophylaxis with tenofovir plus FTC compared to daily regimen Conference reports - Resistance - Intl Drug Resistance Workshop 16 Barbados 2007 - 3 July 2007
- Thirteen NNRTI mutations linked to resistance to etravirine (TMC-125) Conference reports - Resistance - Intl Drug Resistance Workshop 16 Barbados 2007 - 3 July 2007
- Few integrase inhibitor (INI) mutations in INI-naive people Conference reports - Resistance - European Resistance Workshop 5 - 4 May 2007
- Response to darunavir, tipranavir, or lopinavir after atazanavir failure Conference reports - Resistance - European Resistance Workshop 5 - 4 May 2007
- Upper and lower clinical cutoffs proposed for darunavir Conference reports - Resistance - European Resistance Workshop 5 - 4 May 2007
- Accuracy of Monogram’s Trofile assay in determining tropism and new tropism assays in development Conference reports - Resistance - European Resistance Workshop 5 - 4 May 2007
- Several genotyping systems offer hope as tropism predictors Conference reports - Resistance - European Resistance Workshop 5 - 4 May 2007
- Unexpectedly high rate of K65R mutation in patients failing first-line d4T-containing regimens in Thailand Conference reports - Resistance - CROI 14 (Retrovirus) 2007 - 4 April 2007
- Multi-drug resistance in vertically infected children Conference reports - Paediatric care - Resistance - HIV 8 Glasgow 2006 - 6 December 2006
- MK-0518 demonstrates potent efficacy in patients with triple-class resistant virus: 24 week results Conference reports - Resistance - ICAAC 46th San Francisco 2006 - 7 October 2006
- Cell studies predict cross-resistance among integrase inhibitors Conference reports - Resistance - 7 October 2006
- Report from the 10th Annual UK Resistance Meeting, 21 September 2006, London Conference reports - Resistance - Conference index - 7 October 2006
- 15th International Drug Resistance Workshop, 13-17 June 2006, Sitges, Spain Conference reports - Resistance - Conference index - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Resistance implications of monotherapy with lopinavir/r (Kaletra) Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Ritonavir reduces virological failure and resistance in treatment naïve patients treated with atazanavir Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Resistance to darunavir (TMC-114): predicting responses for treatment experienced patients Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Epidemiological studies and transmission of resistance: evidence for optimism – or issues with interpretation? Conference reports - Resistance - Transmission and prevention - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- K103N containing variants persist longer in women with subtype D and with higher viral loads Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- No subtype-based differences in baseline levels of K103N-containing variants in women receiving single dose nevirapine Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Phenotypic NNRTI resistance and genetic diversity in antiretroviral naïve women Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- High prevalence of the K65R mutation in Botswana patients treated with ddI/d4T-based regimens Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Potential for easier selection of K65R mutation with tenofovir pressure in subtype C HIV-1 isolates Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Categorisation of transmitted HIV drug resistance using the WHO/CDC HIV drug resistance threshold survey method may be useful in resource limited settings Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Limitations in online tools to identify HIV-1 subtypes Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Resistance implications from PrEP and microbicide studies in macaques Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Low-level resistance linked to treatment failure: a role for more sensitive testing for naïve patients Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Testing for resistance after starting treatment Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Association between HIV subtype and detection of K103N Conference reports - PMTCT and maternal health - Resistance - CROI 13 (Retrovirus) 2006 - 13 April 2006
- Highlights of HIV drug resistance studies presented at the 3rd IAS Conference Conference reports - Resistance - IAS 3 Rio de Janeiro 2005 - 13 October 2005
- Interaction between tenofovir and ddI in triple-nucleoside combinations: role of M184V in explaining resistance on failure Conference reports - Resistance - Intl Drug Resistance Workshop 14 Quebec 2005 - 14 July 2005
- Predicting clinical responses to ddI from genotypic resistance Conference reports - Resistance - Intl Drug Resistance Workshop 14 Quebec 2005 - 14 July 2005
- Under-detection of transmission of transmitted resistance and impact on treatment response Conference reports - Resistance - Intl Drug Resistance Workshop 14 Quebec 2005 - 14 July 2005
- Risk of death in UK after diagnosis of 3-class resistance Conference reports - Resistance - Intl Drug Resistance Workshop 14 Quebec 2005 - 14 July 2005
- Tenofovir, nucleosides, and non-nucleosides Conference reports - Resistance - European Resistance Workshop 3 - 15 May 2005
- Risk of NNRTI-resistance during STI: implications for SMART and other STI studies Conference reports - Resistance - Intl Drug Resistance Workshop 13 Tenerife 2004 - 29 July 2004
- Persistent nevirapine resistance following mother to child transmission interventions Conference reports - PMTCT and maternal health - Resistance - Intl Drug Resistance Workshop 13 Tenerife 2004 - 29 July 2004
- Tipranavir resistance and viral response: L90M did not reduce response, recommendation to use with T-20 Conference reports - Other news - PMTCT and maternal health - Resistance - Intl Drug Resistance Workshop 13 Tenerife 2004 - 29 July 2004
- Resistance in the UK: new approach to epidemiological studies Conference reports - Resistance - Intl Drug Resistance Workshop 13 Tenerife 2004 - 29 July 2004
- Low AZT activity against HIV-2 infection Conference reports - Resistance - Intl Drug Resistance Workshop 13 Tenerife 2004 - 29 July 2004
- No evidence for cross resistance between nevirapine and d4T Conference reports - Resistance - Intl Drug Resistance Workshop 13 Tenerife 2004 - 29 July 2004
- Case of MDR reinfection with MDR virus Conference reports - Resistance - Intl Drug Resistance Workshop 13 Tenerife 2004 - 29 July 2004
- Understanding developments in HIV drug resistance for new drugs and targets — atazanavir, fusion (T-20) and receptor inhibitors Conference reports - Resistance - European Resistance Workshop 2 - 2 May 2004
- Summary of resistance studies at Retrovirus Conference reports - Resistance - CROI 11 (Retrovirus) 2004 - 3 April 2004
- XII International HIV Drug Resistance Workshop, Los Cabos, Mexico, 10-14 June 2003 Conference reports - Resistance - Conference index - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Transmission of drug resistance – at 11% in Europe and 17% in the UK Conference reports - Resistance - Transmission and prevention - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- HIV coinfection, reinfection and superinfection Conference reports - Hepatitis coinfection - Resistance - Transmission and prevention - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Single-dose nevirapine resistance in over 75% of mothers Conference reports - PMTCT and maternal health - Resistance - Women's health - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Transmission of drug resistant virus does not revert to wild-type and does not appear ‘less fit’ Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Standard genotype assays may miss 75% of mutations when present in less than 35% of plasma sample Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Low-level resistance and minority populations: cross resistance between nevirapine and efavirenz occurs even in the absence of genotypic mutations found using population sequencing Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Persistent effect of d4T and 3TC, but not NNRTIs in the presence of associated genotypic mutations Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Replicative capacity results complicated by minority wild-type virus Conference reports - Resistance - Virology - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Response to STI is determined by virus rather than immunological response Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Why resistance rarely develops with viral suppression <50 copies/mL Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Long-term persistence of distinct mutations in genital tract Conference reports - Resistance - Women's health - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Nevirapine resistance – the cautionary tales continue Conference reports - PMTCT and maternal health - Resistance - CROI 10 (Retrovirus) 2003 - 1 April 2003
- Subtle decreases in stavudine (d4t, Zerit) phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine (AZT, Retrovir)-experienced patients Resistance - 1 March 2003
- Medical care providers have very limited knowledge of resistance-associated drug mutations Resistance - 1 March 2003
- Inhibitory quotient useful as indicator of effective protease inhibitor therapy Resistance - 1 March 2003
- Short resistance reports from Seville Conference reports - Resistance - Intl Drug Resistance Workshop 11 Sitges 2002 - 11 September 2002